• Home
  • News
  • Analysis
  •  
    Regions
    • Australasia
    • Southeast Asia
    • Greater China
    • North Asia
    • South Asia
    • North America
    • Europe
    • Central Asia
    • MENA
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Early stage
    • PIPE
    • Credit
  •  
    Exits
    • IPO
    • Open market
    • Trade sale
    • Buyback
  •  
    Sectors
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
    • Real Estate
  • Events
  • Chinese edition
  • Data & Research
  • Weekly Digest
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Weekly Digest
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      2023-china-216x305
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Healthcare

laser-medical-surgery
Hahn launches tender offer for Korean medical devices player

Hahn & Company has launched a KRW 957bn (USD 735.9m) tender offer for listed Korean medical devices manufacturer Lutronic, working in conjunction with the company’s founder and CEO.

  • North Asia
  • 12 June 2023
syringe-needle-healthcare
PAG invests $200m in India's RK Pharma

PAG has invested USD 200m in RK Pharma, a US-headquartered generic drug maker with significant operations in India.

  • South Asia
  • 08 June 2023
healthifyme
India’s HealthifyMe raises $30m

LeapFrog Investments and Khosla Ventures have led a USD 30m pre-Series D round for India-based mobile health and fitness app HealthifyMe.

  • South Asia
  • 08 June 2023
retirement-aged-care-02
Bain boosts take-private offer for Australia's Estia

Bain Capital has increased its take-private offer for Australia-listed aged care provider Estia Health – to a point where the business is valued at about AUD 826.8m (USD 550m) – after an earlier bid was rejected.

  • Australasia
  • 08 June 2023
baton-race-handover-transition-03
NewQuest, GIC back Everbridge's South Asia continuation fund

NewQuest Capital Partners and GIC have supported a USD 267m continuation fund for Capital Group Private Markets spinout Everbridge Partners, two years after a larger deal involving some of the same assets failed to close amid portfolio volatility.

  • South Asia
  • 07 June 2023
dollar-money-bills-notes-01
Hong Kong's AIA commits $200m to LeapFrog

Hong Kong-listed insurance company AIA Group has agreed to commit USD 200m to various funds managed by LeapFrog Investments, a UK-based impact investor with an extensive Asia footprint.

  • South Asia
  • 07 June 2023
skin-care-face-treatment
Australia's PE-backed Silk Laser set for take-private

Australia-listed Silk Laser Clinics, a non-surgical aesthetics business backed by local PE firm Advent Partners, has signalled it intends to accept a take-private offer from Hong Kong’s EC Healthcare.

  • Australasia
  • 05 June 2023
qic-tvm
Kazakhstan investor backs TVM SE Asia healthcare fund

Qazaqstan Investment Corporation (QIC), a private equity fund-of-funds set up by the Kazakhstan government, has invested in a Southeast Asia fund managed by TVM Capital Healthcare.

  • Central Asia
  • 02 June 2023
xray-diagnostic-image-radiology-05
Australia's GenesisCare files for US bankruptcy protection

GenesisCare, an Australia-headquartered cancer care provider in which KKR holds a minority stake, has filed for bankruptcy protection in the US and announced a restructuring that will separate US operations from those in Australia, Spain, and the UK.

  • Australasia
  • 02 June 2023
healthcare-stethoscope
HighLight updates final close timeline for China healthcare fund

HighLight Capital, a Chinese life sciences investor, has pushed out the final close on its fourth US dollar-denominated fund to the third quarter amid challenging fundraising conditions for the industry.

  • Greater China
  • 31 May 2023
heart-body
Japan's Heartseed raises $14m Series D

Heartseed, a Tokyo-based biotech start-up specializing in treatments that use cardiac muscle cells to initiate the remuscularization of patients who have suffered heart failure, has raised JPY 2bn (USD 14.3m) in Series D funding.

  • North Asia
  • 29 May 2023
tablets-medicine-healthcare-drug
China's Biomissile secures $28m Series B

Suzhou-based Biomissile has raised CNY 200m (USD 28m) in a Series B funding round led by Kequan Capital. Existing investor Fosun Health Capital re-upped.

  • Greater China
  • 22 May 2023
telehealth-telemedicine-healthcare-technology-app
Singapore digital health start-up Ora raises $10m

Singapore-based digital health start-up Ora has raised a USD 10m Series A round led by TNB Aura and Antler. Other participants include Gobi Partners, Kairous Capital, and GMA Ventures.

  • Southeast Asia
  • 19 May 2023
renminbi-rmb
Qiming hits $930m final close on latest renminbi fund

Qiming Venture Partners has closed its seventh renminbi-denominated fund on CNY 6.5bn (USD 930m), marking what it claims is China's largest local currency fundraise of 2023 to date

  • Greater China
  • 18 May 2023
biotech-lab-drug-research-development
China's Drug Farm secures $27m in first tranche of Series C

Drug Farm, a China and US-based developer of treatments for infection and immunological diseases, has raised USD27m in the first tranche of Series C funding led by Shanghai's YD Capital.

  • Greater China
  • 18 May 2023
south-southeast-asia-asean-indo-pacific
South by Southeast: Asia’s next growth engine?

Grouping together markets based on growth and scale is a problematic with South Asia and Southeast Asia as it was with the BRIC economies. But to some extent, investors are buying into the story

  • South Asia
  • 17 May 2023
biotech-lab-healthcare-pharma
China's Coherent Biopharma raises $100m

Chinese cancer-focused biotech developer Coherent Biopharma has raised about USD 100m in Series B funding featuring HM Capital.

  • Greater China
  • 15 May 2023
biotech-lab-healthcare-pharma-01
IDG leads $59m Series A for China’s Taichu Biotech

Shanghai Taichu Biotechnology, a China-based outsourced drug developer focused on novel treatments, has raised a serious A of CNY 400m (USD59m) led by IDG Capital.

  • Greater China
  • 09 May 2023
it-services-technology-software
China insurance tech player raises $43m

Shanghai Kingstar Winning Software, a digital risk control solution provider for insurers, has raised a Series C round of CNY300m (USD 43m) led by China Taiping Insurance Group.

  • Greater China
  • 03 May 2023
straits-orthopaedics
Quadria acquires Malaysia’s Straits Orthopaedics

Singapore-headquartered healthcare specialist Quadria Capital has acquired a majority stake in Malaysian contract devices manufacturer Straits Orthopaedics at an enterprise value of USD 240m.

  • Southeast Asia
  • 02 May 2023
biotech-lab-drug-research-development
Eight Roads leads $38m round for China biotech player Adcentrx

China and US-based biotech company Adcentrx has raised USD38m in an extended Series A round led by Eight Roads Ventures, with participation from F-Prime Capital, ABio-X, Delta Capital, and Trinity Innovation Fund.

  • Greater China
  • 26 April 2023
tablets-medicine-healthcare-drug
Deal focus: CBC gets counterintuitive in China

CBC Group has helped multiple start-ups move from in-licensing to drug development to commercialisation. With China’s Hasten, it is navigating this tried-and-tested journey in reverse

  • Greater China
  • 26 April 2023
biotech-lab-healthcare-pharma-03
GL Capital leads $290m investment in China’s Sangon Biotech

Chinese healthcare-focused private equity firm GL Capital has led a CNY2bn (USD 290m) investment in local life sciences company Sangon Biotech.

  • Greater China
  • 24 April 2023
pills-drugs-pharma-3
CBC, Mubadala lead $315m round for China's Hasten Biopharma

Specialist healthcare investor CBC Group and Mubadala Investment have led a USD 315m round for China-based Hasten Biopharmaceutic, with participation from other undisclosed institutional investors.

  • Deals
  • 21 April 2023
3 4 5
  • About AVCJ
  • Advertise
  • Contacts
  • About ION Analytics
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013